Penn Medicine Hypertension, Lipids, and Approaches to Cardiovascular Pharmacologic Risk Reduction: What’s New in 2022 (Videos + PDFs)
Advanced Preventive Cardiology, Hypertension, Lipid Management & Cardiometabolic Risk Reduction
Overview
Penn Medicine Hypertension, Lipids, and Approaches to Cardiovascular Pharmacologic Risk Reduction: What’s New in 2022 is a comprehensive preventive cardiology program focused on the latest evidence-based strategies for reducing cardiovascular risk through optimal management of hypertension, dyslipidemia, diabetes, chronic kidney disease, and other cardiometabolic conditions.
Held virtually on September 30, 2022, this educational conference reviews contemporary clinical guidelines, emerging pharmacologic therapies, and practical approaches to cardiovascular prevention in high-risk patient populations. Faculty members provide expert guidance on integrating modern cardiovascular risk reduction therapies into everyday clinical practice while addressing complex management scenarios involving diabetes, chronic kidney disease, pregnancy, and vulnerable patient groups.
This course is particularly valuable for clinicians seeking updates on preventive cardiology, lipid management, hypertension treatment, and the rapidly evolving field of cardiometabolic medicine.
Course Highlights
- 13 Expert-Led Video Lectures
- 16 Downloadable PDF Presentations
- Preventive Cardiology Updates
- Hypertension Management Guidelines
- Lipid Management & Dyslipidemia Treatment
- Diabetes & Cardiovascular Disease Prevention
- Chronic Kidney Disease (CKD) Updates
- Cardiometabolic Risk Reduction Strategies
- Pharmacologic & Non-Pharmacologic Prevention Approaches
- Evidence-Based Clinical Guideline Reviews
Learning Objectives
Upon completion of this course, participants will be able to:
- Select appropriate pharmacologic therapies to reduce cardiovascular events in high-risk populations.
- Apply current hypertension treatment guidelines and blood pressure targets.
- Optimize lipid-lowering therapies for cardiovascular prevention.
- Integrate diabetes and chronic kidney disease therapies into cardiovascular risk management.
- Evaluate cardiovascular risk in special populations, including pregnant women and younger patients.
- Utilize evidence-based screening and prevention strategies.
- Apply both pharmacologic and lifestyle-based approaches to cardiovascular risk reduction.
- Improve outcomes through individualized preventive cardiology management.
Major Topics Covered
Preventive Cardiology
The course focuses on reducing cardiovascular morbidity and mortality through proactive prevention strategies.
Topics Include
- Primary prevention
- Secondary prevention
- Cardiovascular risk assessment
- Risk factor modification
- Population health strategies
- Evidence-based prevention programs
Participants learn practical approaches to identifying and managing patients at elevated cardiovascular risk.
Hypertension Management
A major component of the course reviews contemporary approaches to blood pressure control.
Covered Topics
- Updated hypertension guidelines
- Blood pressure targets
- Resistant hypertension
- Hypertension in special populations
- Hypertension and cardiovascular outcomes
- Individualized treatment strategies
Faculty discuss how optimal blood pressure management remains one of the most effective methods of preventing cardiovascular disease.
Lipid Management & Dyslipidemia
The program provides extensive updates on modern cholesterol management.
Topics Include
- LDL cholesterol reduction
- Statin therapy optimization
- Non-statin therapies
- PCSK9 inhibitors
- Hyperlipidemia management
- Cardiovascular risk reduction through lipid control
Participants review current recommendations for both primary and secondary prevention.
Diabetes & Cardiovascular Disease
The course explores the critical relationship between diabetes and cardiovascular outcomes.
Covered Topics
- Type 2 diabetes management
- Cardiovascular complications of diabetes
- Cardiometabolic disease
- Novel glucose-lowering therapies
- Risk reduction strategies
- Integrated diabetes and cardiovascular care
Special attention is given to therapies that provide both glycemic and cardiovascular benefits.
Chronic Kidney Disease (CKD) & Cardiovascular Risk
Kidney disease significantly increases cardiovascular risk.
Topics Include
- CKD screening
- Cardiovascular risk in CKD
- Blood pressure management in CKD
- Kidney-protective therapies
- Pharmacologic interventions
- Multidisciplinary management
Faculty review emerging therapies that improve both renal and cardiovascular outcomes.
Pharmacologic Cardiovascular Risk Reduction
The symposium highlights advances in medications that target underlying cardiovascular disease mechanisms.
Topics Include
- Antihypertensive medications
- Lipid-lowering agents
- Diabetes therapies
- Combination treatment strategies
- High-risk patient management
- Emerging cardiovascular therapeutics
The emphasis is on selecting therapies that reduce major adverse cardiovascular events.
Cardiovascular Prevention in Special Populations
Specialized sessions address unique patient populations.
Discussion Areas
- Pregnancy and cardiovascular disease
- Maternal cardiovascular risk
- Young adults with hypertension and hyperlipidemia
- Geriatric cardiovascular prevention
- High-risk vulnerable populations
Participants learn how treatment strategies must be individualized based on patient-specific characteristics.
Lifestyle & Non-Pharmacologic Prevention
The course emphasizes that effective cardiovascular prevention extends beyond medication therapy.
Topics Include
- Dietary modification
- Weight management
- Exercise and physical activity
- Smoking cessation
- Stress reduction
- Lifestyle-based cardiovascular prevention
These interventions remain foundational components of cardiovascular risk management.
Clinical Guidelines & Evidence-Based Practice
Faculty review contemporary guideline recommendations and emerging clinical evidence.
Topics Include
- Hypertension guideline updates
- Lipid management recommendations
- Diabetes management standards
- CKD treatment pathways
- Preventive cardiology best practices
The focus is on translating evidence into real-world clinical care.
Educational Features
✔ Comprehensive preventive cardiology update
✔ Hypertension guideline review
✔ Lipid management education
✔ Diabetes and cardiovascular risk reduction
✔ Chronic kidney disease updates
✔ Pharmacologic prevention strategies
✔ Special population management
✔ Lifestyle medicine integration
✔ Evidence-based treatment recommendations
✔ Practical clinical application
Who Should Attend?
This course is ideal for:
- Cardiologists
- Preventive Cardiologists
- Endocrinologists
- Nephrologists
- Internal Medicine Physicians
- Family Medicine Physicians
- Primary Care Physicians
- Advanced Heart Failure Specialists
- Interventional Cardiologists
- Obstetricians & Maternal-Fetal Medicine Specialists
- Nurse Practitioners
- Physician Assistants
- Preventive Medicine Specialists
Why This Course Stands Out
✔ Dedicated focus on cardiovascular prevention
✔ Covers hypertension, lipids, diabetes, and CKD in one program
✔ Reviews latest clinical guidelines and therapeutic advances
✔ Practical approach to high-risk patient management
✔ Strong emphasis on cardiometabolic medicine
✔ Integrates pharmacologic and lifestyle interventions
✔ Applicable to both specialty and primary care practice
✔ Evidence-based and guideline-driven curriculum
✔ Addresses contemporary controversies and treatment gaps
✔ Led by experts in preventive cardiovascular medicine
Topics:
- BP Goals and Use of Thiazides in Advanced CKD.mp4
BP Goals and Use of Thiazides in Advanced CKD.pdf
BP Goals Management in Elderly (STEP Trial and SPRINT).mp4
BP Goals Management in Elderly (STEP Trial and SPRINT).pdf
BP22_Brochure_v4.pdf
Cholesterol.mp4
Cholesterol.pdf
Clinical Case Discussion FOUNDATIONS- REFRESHER OF THE CURRENT GUIDELINES.pdf
Clinical Case Discussion SPECIAL POPULATIONS.pdf
DM Weight loss.mp4
DM Weight loss.pdf
Hypertension.mp4
Hypertension.pdf
Lipid Management and Risk Assessment in Younger Patients.mp4
Lipid Management and Risk Assessment in Younger Patients.pdf
New Agents in Lipid Management.mp4
New Agents in Lipid Management.pdf
Non-steroidal MRAs in HTN, DM2, and CKD.mp4
Non-steroidal MRAs in HTN, DM2, and CKD.pdf
Peripartum CV Risk Reduction.mp4
Peripartum CV Risk Reduction.pdf
Polypill – Quad Study Combo Therapy for BP and Lipids.mp4
Polypill – Quad Study Combo Therapy for BP and Lipids.pdf
Population-Wide Effects and Local Public Health Efforts of Sodium Reduction.mp4
Population-Wide Effects and Local Public Health Efforts of Sodium Reduction.pdf
Update in Renal Denervation.mp4
Update in Renal Denervation.pdf
Weight Loss Strategies in Highly Comorbid Patients.mp4
Weight Loss Strategies in Highly Comorbid Patients.pdf








